8
Oct
2024

Colorcon Limited

Exhibitor at CPHI Milan 2024 stand 6D58, Excipients
About Us

Colorcon is a world leader in the development, supply and technical support of film coating systems, modified release technologies, specialty excipients and functional packaging for the healthcare industries. Our innovative products and technologies are complemented by our value-added services, supporting all phases of solid dose design, development, and manufacture.


  • GB
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Contract Service
Manufacturer/Innovator
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 6D58, Excipients

Products Featured at CPHI Milan 2024

  • Controlled Release

    Product Controlled Release

    Colorcon offers an enhanced portfolio of polymers for controlled release drug delivery systems along with application expertise to meet customers’ formulation needs and help speed their products to market.
  • Functional Packaging

    Product Functional Packaging

    To maintain potency, stability, and shelf life, pharmaceuticals and healthcare products often require highly protective and active packaging. Colorcon now provides critical industries with high-quality, controlled atmosphere packaging, so they can protect their products from moisture and oxygen.
  • HyperStart C2C Smart Formulation Hub

    Product HyperStart C2C Smart Formulation Hub

    Digital self-serve platform to boost R&D productivity through interactive formulation development.
  • Opadry Complete Film Coating Systems

    Product Opadry Complete Film Coating Systems

    Colorcon offers a wide range of film coating products, all of which can be formulated specifically for your application and regulatory requirements. Whether the desired function for your tablet or multiparticulate dosage is immediate release, enteric release and/or sustained release, we have the film coati...
  • Specialty Excipients

    Product Specialty Excipients

    In the development of a solid oral dosage form, the choice of the core excipients is extremely important. Key aspects for consideration are the nature of the active pharmaceutical ingredient (API) itself; the intended delivery method of the API (immediate or modified release) and the manufacturing process.